Recent advances in human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) biology enable generation of dopaminergic neurons for potential therapy and drug screening. However, our current understanding of molecular and cellular signaling that controls human dopaminergic development and function is limited. Here, we report on a whole genome analysis of gene expression during dopaminergic differentiation of human ESC/iPSC using Illumina bead microarrays. We generated a transcriptome data set containing the expression levels of 28,688 unique transcripts by profiling five lines (three ESC and two iPSC lines) at four stages of differentiation: (1) undifferentiated ESC/iPSC, (2) neural stem cells, (3) dopaminergic precursors, and (4) dopaminergic neurons. This data set provides comprehensive information about genes expressed at each stage of differentiation. Our data indicate that distinct pathways are activated during neural and dopaminergic neuronal differentiation. For example, WNT, sonic hedgehog (SHH), and cAMP signaling pathways were found over-represented in dopaminergic populations by gene enrichment and pathway analysis, and their role was confirmed by perturbation analyses using RNAi (small interfering RNA of SHH and WNT) or small molecule [dibutyryl cyclic AMP (dcAMP)]. In summary, whole genome profiling of dopaminergic differentiation enables systematic analysis of genes/pathways, networks, and cellular/molecular processes that control cell fate decisions. Such analyses will serve as the foundation for better understanding of dopaminergic development, function, and development of future stem cell-based therapies.
IntroductionD opaminergic neurons form a neurotransmitter system that originates in the substantia nigra pars compacta, ventral tegmental area, and hypothalamus. Several diseases of the central nervous system, such as Parkinson's disease (PD), schizophrenia, and attention deficit hyperactivity disorder, are associated with dysfunctions of the dopamine system. Knowledge of the molecular mechanisms that regulate human dopaminergic development and function may provide better understanding of the causes for these diseases and offer clues for new treatments. The development and function of human dopaminergic neurons remain relatively uncharacterized at the molecular level compared to rodents. Therefore, studies of the underlying molecular mechanisms of the above-mentioned diseases have been largely hampered by the limited availability of human cells at the appropriate stages of dopaminergic development.The recent advances in human pluripotent stem cell (PSC) biology enable reprogramming of human adult somatic cells from healthy subjects and patients to induced pluripotent stem cells (iPSC) [1,2]. The reprogramming technology and derivation of iPSC followed by their differentiation allow the generation of sufficient numbers of human dopaminergic neurons at different stages of development for both in vitro and in vivo studies. Several groups have reported on the generation of functional ...